. 2017 Jan 1;8(1):82–90. doi: 10.6004/jadpro.2017.8.1.7
Copyright © 2017, Harborside Press
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
Table 5.
Pre- and Postinfusion Medications for Daratumumab